Fedratinib

Inrebic

Near Add Your Location

Accepting patients

Decitabine Plus a JAK-Inhibitor

A Phase 2 Trial Investigating Decitabine in Combination With a JAK-Inhibitor as a Bridge to Allogeneic Hematopoietic Stem Cell Transplant in Patients With Accelerated/Blast Phase Myeloproliferative Neoplasms
Learn more
  • Hypomethylating Agents (HMA)
  • JAK1 Inhibitor
  • JAK2 Inhibitor
  • Phase 2

Accepting patients

Fedratinib

A Phase 2 Study of Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL)
Learn more
  • JAK2 Inhibitor
  • Phase 2
  • Has results